Skip to content

M&A Push to Secure a Slice of the Gene Therapy Opportunity

Justin Wilson, a partner and life sciences specialist at European intellectual property firm, Withers & Rogers explores why M&A are pushing to secure a slice of the gene therapy opportunity.

M&A Push to Secure a Slice of the Gene Therapy Opportunity
Published: | 3 min read

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information